Oral Anti articles & resources on Made-in-China.com

Availability of ONFI in Scored Tablet and Oral Suspension Formulations

Aug 15, 2013

Danish drugmaker Lundbeck has announced the availability of ONFI (clobazam) in scored tablet and oral suspension formulations in the US pharmacies beginning this week. ONFI, an oral anti-epileptic drug (AED) of the benzodiazepine class, ...

Tags: Lundbeck, Drug ONFI

Celgene's Pomalidomide Oral Anti-cancer Therapy Has Won European Commission Approval

Aug 13, 2013

Celgene International's oral anti-cancer therapy Pomalidomide has won European Commission approval as treatment for patients with relapsed/refractory multiple myeloma (rrMM), a rare form of blood cancer, in combination with dexamethasone. ...

Tags: Anti-Cancer Therapy

The EMA Committee for CHMP Has Adopted a Positive Opinion

Jun 4, 2013

The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Celgene International's oral anti-cancer therapy Pomalidomide. The positive results from the MM-003 study of ...

Tags: Health, Medicine

Phase III Trial Results of Oral Insulin Generex Oral-Lyn to Indian Government for Approval

Jan 25, 2013

Canada’s Generex Biotechnology, through its Indian licensee Shreya Life Sciences, has submitted a dossier of recently concluded Phase III trial results of its oral insulin ‘Generex Oral-lyn’ to the Indian government for ...

Tags: Generex Biotechnology, Shreya Life Sciences, oral insulin

Poxel Has Raised $17m in a Series B Round Financing

Dec 20, 2012

Poxel has raised €13m ($17m) in a series B round financing to develop and confirm efficacy data of Imeglimin, a drug used to treat type 2 diabetes. Imeglimin is a new tetrahydrotriazine-containing class of oral anti- diabetics, the ...

Tags: Poxel, efficacy data of Imeglimin, drug, ype 2 diabetes

Sanofi Has Opened a Lantus Solostar Pen Assembly Plant in Beijing,China

Dec 18, 2012

Sanofi, a provider of diabetes devices, has opened a Lantus SoloSTAR Pen assembly plant in Beijing, china. The Lantus SoloSTAR plant with a capacity of 48 million units per year is designed to produce Lantus SoloSTAR pre-filled insulin ...

Tags: Sanofi, assembly plant, diabetes devices, Lantus SoloSTAR plant

Boehringer Is Set to Launch Diabetes in India with Eli Lilly

Nov 27, 2012

Boehringer Ingelheim India and Eli Lilly India is set to launch Linagliptin (brand name trajenta) 5mg film-coated tablets, for Type 2 diabetes in adults, in India. Linagliptin, which is approved in the US, the European Union, Japan and ...

Tags: Diabetes Drug, product of Boehringer, diabetes epidemic

Nanoviricides Has Reported Effectiveness of an Anti-Influenza Drug Candidate

Aug 16, 2012

NanoViricides, a development stage company, has reported effectiveness of an anti-influenza drug candidate, under FluCide program, when given orally. According to the information received from the contract laboratory that performed the ...

Tags: anti-influenza drug candidate, Medicine, Oral Anti

Oral Anti

Related Products